Drug Search Results
More Filters [+]

Quinfamide

Alternative Names: quinfamide
Latest Update: 2015-04-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Colombia | Dominican Republic | Ecuador | Mexico

Approved Indications: None

Known Adverse Events: None

Company: Johnson & Johnson
Company Location: NEW BRUNSWICK NJ 08933
Company CEO: Joaquin Duato
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Quinfamide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Dysentery, Amebic|Amebiasis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CR003685

P4

Completed

Dysentery, Amebic|Amebiasis

2006-01-01

Recent News Events

Date

Type

Title